News
To diagnose non-Hodgkin‘s lymphoma, doctors may use blood tests, biopsies, and imaging scans such as CT scans or MRIs. These tests help doctors confirm the presence of the disease and plan the ...
A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana, has found that service members were diagnosed at younger ages ...
The “Full House” star, 65, recently revealed that he learned he became a grandfather on the same day he learned he had beaten his battle with Stage 3 non-Hodgkin’s lymphoma. Coulier shared ...
This lawsuit, commenced in June 2019, centers on allegations that Roundup and other glyphosate-based herbicides cause Non-Hodgkin's Lymphoma ("NHL"), (a type of cancer) and that the Defendants ...
The ongoing Phase 1 clinical trial of ARV-393 in relapsed/refractory non-Hodgkin lymphoma highlights the company's commitment to bringing innovative therapies to the market for patients in need.
has initiated a Phase 1 clinical trial for a novel radioimmunotherapy treatment targeting non-Hodgkin Lymphoma (NHL). The first patient has received the initial protein and imaging doses as part ...
for evaluating the company’s Self-Assembly and Disassembly (SADA) Pre-targeted Radioimmunotherapy (PRIT) platform in treating relapsed or refractory non-Hodgkin Lymphoma (r/r NHL). This trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results